XML 18 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
6 Months Ended
Jul. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Activity under Company's Stock Option Plans

A summary of activity under the Company’s stock option plans for the six months ended July 31, 2014 is presented below:

 

Options

   Shares     Weighted
Average
Exercise

Price
     Weighted
Average
Remaining
Contract
Term (Years)
     Weighted
Average
Fair

Value
 

Outstanding, January 31, 2014

     916,150      $ 17.36         6.04       $ 5.58   

Granted

     180,500      $ 27.09                  

Exercised

     (153,800 )   $ 14.84                   
  

 

 

         

Outstanding, July 31, 2014

     942,850      $ 19.63         6.65       $ 5.72   
  

 

 

         

Exercisable, July 31, 2014

     540,350      $ 15.67         5.92       $ 5.91   
  

 

 

         

Exercisable, January 31, 2014

     613,150      $ 15.40         5.09       $ 6.15   
  

 

 

         
Summary of Change in Number of Non-Vested Options to Purchase Shares of Common Stock

A summary of the change in the number of non-vested options to purchase shares of common stock for the six months ended July 31, 2014 is presented below:

 

     Shares     Weighted
Average
Fair Value
 

Nonvested, January 31, 2014

     303,000      $ 4.40   

Granted

     180,500      $ 6.28   

Vested

     (81,000   $ 3.30   
  

 

 

   

Nonvested, July 31, 2014

     402,500      $ 5.46   
  

 

 

   
Summary of Assumptions Used to Estimate Fair Value of Stock Options Granted

The fair value of each stock option granted in the six-month period ended July 31, 2014 was estimated on the corresponding date of award using the Black-Scholes option-pricing model based on the following weighted average assumptions. No awards were made during the three months ended July 31, 2014.

 

     Six Months Ended
July 31, 2014
 

Dividend yield

     2.77

Expected volatility

     33.83

Risk-free interest rate

     1.26

Expected life in years

     4.81